Table 2.

Effect of BBLE treatment on serum parameter in HFD-induced obesity mouse model C57BL/6J mice

	Group
	N	C	PC	B
WBC (k/μl)	10.158 ± 0.429	14.652 ± 0.329	9.9475 ± 0.517	10.599 ± 0.126
Neutrophil (k/μl)	4.635 ± 0.288	6.192 ± 0.313	4.0675 ± 0.227	4.493 ± 0.155
Lymphocyte (k/μl)	5.375 ± 0.228	8.198 ± 0.314	5.6125 ± 0.447	5.803 ± 0.078
Monocyte (k/μl)	0.1325 ± 0.127	0.216 ± 0.123	0.24 ± 0.093	0.266 ± 0.058
Eosinophil (k/μl)	0.0175 ± 0.005	0.036 ± 0.015	0.0175 ± 0.01	0.03 ± 0.017
Basophil (k/μl)	0.0025 ± 0.005	0.01 ± 0.012	0.005 ± 0.006	0.0033 ± 0.006
RBC (M/μl)	683 ± 14.468	843.6 ± 8.385	675.75 ± 10.436	712 ± 8.544
Hb (g/dl)	17.375 ± 0.206	21.56 ± 0.688	17.15 ± 0.404	17.9 ± 0.265
HCT (%)	49.55 ± 0.624	54.34 ± 0.627	47.175 ± 0.299	47.666 ± 0.513
Platelet (k/μl)	700 ± 19.494	855.8 ± 22.521	704.25 ± 14.408	717.333 ± 23.072
AST (U/L)	74.60 ± 3.13	122.60 ± 3.85	75.00 ± 3.37	88.67 ± 3.06
ALT (U/L)	57.00 ± 2.12	87.00 ± 2.24	57.50 ± 2.38	69.33 ± 0.58
ALP (U/L)	172.80 ± 3.42	276.20 ± 6.14	183.50 ± 3.42	189.33 ± 2.52
LDH (mmol/mL)	332.00 ± 13.04*	548.00 ± 11.77	390.50 ± 4.20*	400.67 ± 8.33*
HDL-C (mmol/mL)	118.00 ± 3.39	78.60 ± 2.97	99.50 ± 6.03	102.67 ± 6.03
LDL-C (mmol/mL)	42.60 ± 3.51*	133.60 ± 3.78	90.25 ± 3.77*	97.67 ± 4.04*
Glucose (mmol/mL)	80.4 ± 4.22	126.40 ± 6.27	90.0 ± 3.65	94.67 ± 4.16
Insulin (μU/mL)	21.34 ± 1.75	41.98 ± 1.33	24.50 ± 1.00	24.33 ± 1.15
TG (mg/dL)	43.00 ± 5.70*	174.40 ± 4.28	94.00 ± 1.83*	88.33 ± 6.11*
T-CHOL (mg/dL)	59.00 ± 1.58	117.00 ± 4.69	83.50 ± 2.65	100.00 ± 6.00

K/μL: ×10³/mm³, M/μL: ×10⁶/mm³. Data are expressed as means ± s.d. (n = 6). Duncan’s test:

^*P < 0.01 significantly from the value of the HFD group. WBC, white blood cell; RBC, red blood cell; Hb, hemoglobin; HCT, hematocrit; AST, aspartate aminotransferase; ALT, alanine transaminase; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; HDL-C, high density lipoprotein-cholesterol; LDL-C, low density lip-oprotein-cholesterol; TG, triglycerides; T-CHOL, total cholesterol.